Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan

Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan

Introduction: Kras mutation is the most common driver oncogene present in patients with NSCLC. Recently, the precision medicine for patients with Kras-mutated NSCLC has been under investigation, but the best treatment is still unknown. This study aimed to analyze the clinical characteristics, immune...

Full description

Bibliographic Details
Main Authors: Shang-Gin Wu, MD, PhD, Wei-Yu Liao, MD, PhD, Kang-Yi Su, PhD, Sung-Liang Yu, PhD, Yen-Lin Huang, MD, Chong-Jen Yu, MD, PhD, James Chih-Hsin Yang, MD, PhD, Jin-Yuan Shih, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:JTO Clinical and Research Reports
Subjects:
Kras mutation
G12C
Lung cancer
Immunotherapy
PD-L1
Concomitant mutation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320301910

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320301910

Similar Items